Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilka Rauert-Wunderlich

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|February 26, 2016
Targeting protein kinase C in mantle cell lymphomaHilka Rauert-Wunderlich, Martina Rudelius, German Ott, et al.
Cell Death & Disease|January 26, 2018
CD40L mediated alternative NFκB-signaling induces resistance to BCR-inhibitors in patients with mantle cell lymphomaHilka Rauert-Wunderlich, Martina Rudelius, Ingolf Berberich, et al.
Plos One|March 26, 2013
The IKK inhibitor Bay 11-7082 induces cell death independent from inhibition of activation of NFκB transcription factorsHilka Rauert-Wunderlich, Daniela Siegmund, Eduard Maier, et al.
Virchows Archiv : an International Journal of Pathology|October 11, 2022
Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world seriesAlberto Zamò, Elena Gerhard-Hartmann, German Ott, et al.
International Journal of Molecular Sciences|March 6, 2021
Time-Resolved scRNA-Seq Tracks the Adaptation of a Sensitive MCL Cell Line to Ibrutinib TreatmentViktoria Fuhr, Ehsan Vafadarnejad, Oliver Dietrich, et al.
Pathologie (Heidelberg, Germany)|October 12, 2022
[scRNA-sequencing uncovers metabolism and CD52 as new targets in ibrutinib-surviving mantle cell lymphoma cells]Viktoria Fuhr, Ehsan Vafadarnejad, Oliver Dietrich, et al.
Cell Death Discovery|December 31, 2022
CD52 and OXPHOS-potential targets in ibrutinib-treated mantle cell lymphomaViktoria Fuhr, Shanice Heidenreich, Mugdha Srivastava, et al.
Haematologica|October 29, 2017
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironmentMartina Rudelius, Mathias Tillmann Rosenfeldt, Ellen Leich, et al.
Cell Death & Disease|August 14, 2019
The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1<sup>+</sup> subgroup of multiple myeloma cells for TNF-induced cell deathMohamed El-Mesery, Tina Rosenthal, Hilka Rauert-Wunderlich, et al.
Leukemia & Lymphoma|December 23, 2020
Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphomaCarmen Nordmo, Gunther Glehr, Michael Altenbuchinger, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|February 26, 2016
Targeting protein kinase C in mantle cell lymphomaHilka Rauert-Wunderlich, Martina Rudelius, German Ott, et al.
Cell Death & Disease|January 26, 2018
CD40L mediated alternative NFκB-signaling induces resistance to BCR-inhibitors in patients with mantle cell lymphomaHilka Rauert-Wunderlich, Martina Rudelius, Ingolf Berberich, et al.
Plos One|March 26, 2013
The IKK inhibitor Bay 11-7082 induces cell death independent from inhibition of activation of NFκB transcription factorsHilka Rauert-Wunderlich, Daniela Siegmund, Eduard Maier, et al.
Virchows Archiv : an International Journal of Pathology|October 11, 2022
Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world seriesAlberto Zamò, Elena Gerhard-Hartmann, German Ott, et al.
International Journal of Molecular Sciences|March 6, 2021
Time-Resolved scRNA-Seq Tracks the Adaptation of a Sensitive MCL Cell Line to Ibrutinib TreatmentViktoria Fuhr, Ehsan Vafadarnejad, Oliver Dietrich, et al.
Pathologie (Heidelberg, Germany)|October 12, 2022
[scRNA-sequencing uncovers metabolism and CD52 as new targets in ibrutinib-surviving mantle cell lymphoma cells]Viktoria Fuhr, Ehsan Vafadarnejad, Oliver Dietrich, et al.
Cell Death Discovery|December 31, 2022
CD52 and OXPHOS-potential targets in ibrutinib-treated mantle cell lymphomaViktoria Fuhr, Shanice Heidenreich, Mugdha Srivastava, et al.
Haematologica|October 29, 2017
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironmentMartina Rudelius, Mathias Tillmann Rosenfeldt, Ellen Leich, et al.
Cell Death & Disease|August 14, 2019
The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1<sup>+</sup> subgroup of multiple myeloma cells for TNF-induced cell deathMohamed El-Mesery, Tina Rosenthal, Hilka Rauert-Wunderlich, et al.
Leukemia & Lymphoma|December 23, 2020
Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphomaCarmen Nordmo, Gunther Glehr, Michael Altenbuchinger, et al.
Pageof 3